Speaker illustration

Doctor Ruben Schleberger

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality - insights from the german ablation registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Catheter Ablation of Arrhythmias

Session: Congress committee e-posters choice in arrhythmias and device therapy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb